Protocol Ledger

NCT07678931 · Phase III · RECRUITING

Study on the Treatment of Adolescent Patients With Seasonal Allergic Rhinitis

Interventional Phase III clinical trial protocol NCT07678931 sponsored by Chengdu Kangnuoxing Biopharma in Respiratory and Pulmonary, reconciled from NIH NLM ClinicalTrials.gov REST API v2.

Start Date: 2026-08-13 Enrollment: 136 participants (ESTIMATED) Federal Source: clinicaltrials.gov/study/NCT07678931
Track in Studio / Generate Client Brief ->
Registered Enrollment vs Phase II/III Median (145 pts)136 participants (ESTIMATED)
Disclosed U.S. Hospital Campuses vs Median (6 sites)4 sites

Reconciled ClinicalTrials.gov v2 Protocol Specification

Structured Registry Fields for NCT07678931
Protocol FieldVerified Registry Value
NCT IdentifierNCT07678931
Consolidated Lead SponsorChengdu Kangnuoxing Biopharma
Therapeutic Condition CohortRespiratory and Pulmonary
Clinical Trial PhasePhase III
Overall Recruitment StatusRECRUITING
Registered Enrollment136 participants (ESTIMATED)
Registered Start Date2026-08-13
WhyStopped ClassificationNot Stopped

Named U.S. Hospital Clinical Research Sites

Search related sites and sponsors in the Interactive Directory, explore Respiratory and Pulmonary Benchmarks, or read the Healthcare Price & Patent Cliff Crosswalk.

Need custom healthcare data pipelines, identifier crosswalks, or workflow automation? Talk to Meru AI